<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03409055</url>
  </required_header>
  <id_info>
    <org_study_id>PONTOS-Effusions</org_study_id>
    <nct_id>NCT03409055</nct_id>
  </id_info>
  <brief_title>Pleural Effusions After Cardiac Surgery</brief_title>
  <official_title>Pleural Effusions Are Associated With Adverse Outcomes After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pleural effusions occur commonly in patients recovering from cardiac surgery, however, the&#xD;
      impact on outcomes is not well characterized. The purpose of this study is to characterize&#xD;
      the outcomes of cardiac surgery patients with pleural effusions.&#xD;
&#xD;
      All patients undergoing cardiac surgery between 2006 and 2019 were included in this&#xD;
      observational, cross-sectional analysis using propensity matching.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pleural effusions are common in patients recovering from cardiac surgery. Symptomatic&#xD;
      patients with pleural effusions complain of shortness of breath, cough, chest pain and are&#xD;
      more hypoxic and tachypneic. Clinically significant effusions can slow recovery in the&#xD;
      hospital and beyond, and are a critical source of hospital readmissions after discharge. It&#xD;
      is not well characterized how this impacts hospital outcomes. Further it is unknown if the&#xD;
      effusions themselves are associated with impaired outcomes, or if pleural effusions simply&#xD;
      arise in more complicated, older patients, thus suggesting the impaired outcomes are the&#xD;
      result of coexisting morbidities. To better understand the impact of this complication and to&#xD;
      address the question mentioned before, this study was carried out to determine the clinical&#xD;
      and economic outcomes of pleural effusions in propensity-matched patients during early&#xD;
      recovery from cardiac surgery. To compare patient groups with and without pleural effusion,&#xD;
      the following baseline characteristics were used: e.g. age, sex, body-mass-index, priority of&#xD;
      surgery, type of surgery, duration of surgery, APACHE II Score of patients on admission in&#xD;
      the ICU.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2006</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>an average of 30 days</time_frame>
    <description>In-Hospital mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>hospital stay</measure>
    <time_frame>an average of 30 days</time_frame>
    <description>Length of hospital stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need of drainage</measure>
    <time_frame>an average of 30 days</time_frame>
    <description>Incidence of drainage in patients with pleural effusions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>extubation</measure>
    <time_frame>an average of 15 hours</time_frame>
    <description>time to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal replacement</measure>
    <time_frame>an average of 30 days</time_frame>
    <description>incidence of renal replacement therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>transfusions</measure>
    <time_frame>an average of 30 days</time_frame>
    <description>number of transfusions needed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>an average of 15 days</time_frame>
    <description>Length of Intensive Care Unit (ICU) stay</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">11198</enrollment>
  <condition>Pleura; Effusion</condition>
  <arm_group>
    <arm_group_label>Group 0</arm_group_label>
    <description>patients without pleural effusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>patients with pleural effusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>patients with pleural Effusion and need of drainage</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All adult male and female patients who have undergone cardiac surgery in the period&#xD;
        01/06-12/19 at Campus Mitte in the Charité, approx. 11,000 patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  In-patients of the Charité Universitätsmedizin Berlin&#xD;
&#xD;
          -  at least 18 years old&#xD;
&#xD;
          -  female or male sex&#xD;
&#xD;
          -  cardiosurgical intervention (OPS 5.35 and 5.36) between 01/06 and 12/19&#xD;
&#xD;
          -  post-operative monitoring in the intensive care unit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous cardiosurgical interventions during the same hospital stay&#xD;
&#xD;
          -  incomplete documentation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix Balzer, MD, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité - Universitaetsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 18, 2018</study_first_submitted>
  <study_first_submitted_qc>January 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2018</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Felix Balzer</investigator_full_name>
    <investigator_title>Prof. Dr. med. Dr. rer. nat., MSc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

